Project Details
Description
A phase III multi-centre randomised, double blind, placebo controlled trial to assess the role of intravenous immunoglobulin in the management of children with encephalitis (The IgNiTE study)
| Status | Active |
|---|---|
| Effective start/end date | 21/04/16 → … |
| Links | http://www.hra.nhs.uk/news/research-summaries/ignite-immunoglobulin-in-the-treatment-of-encephalitis/ |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.